Home › Funds › Nantahala Capital Management, LLC › ABVX

Nantahala Capital Management, LLC position in ABVX

ABIVAX SA · Health Care

Nantahala Capital Management, LLC reported holding 198,745 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$19.7M, representing 0.90% of its reported portfolio and ranking #39 among its reported holdings. Nantahala Capital Management, LLC has disclosed ABVX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)198.75K sh
Reported value held$19.68M
Portfolio Weight0.90%
First reportedQ4 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's ABVX position evolved

Nantahala Capital Management, LLC first disclosed a stake in ABVX in Q4 2023 at 1,010,034 shares (US$10.8M). The position peaked in Q3 2025 at 557,564 shares, worth US$47.3M. Across 12 filings, Nantahala Capital Management, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 198,745 shares valued at US$19.7M — an increase of 64,986 shares quarter over quarter.. Notable position changes include a 62% trim in Q3 2025 (shares rose 59% over the following quarter), a 73% trim in Q4 2025 (shares fell 17% over the following quarter), a 49% increase in Q3 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.01M $10.81M New
Q1 2024 1.01M $14.44M Hold
Q2 2024 985.63K $13.03M Reduce
Q3 2024 985.63K $11.35M Hold
Q4 2024 1.44M $10.51M Add
Q1 2025 1.48M $9.27M Add
Q2 2025 1.48M $11.34M Hold
Q3 2025 557.56K $47.34M Reduce
Q4 2025 153.24K $20.66M Reduce
Q1 2026 137.24K $15.28M Reduce
Q2 2026 133.76K $17.82M Reduce
Q3 2026 198.75K $19.68M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 70 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Nantahala Capital Management, LLC held ABVX?

Nantahala Capital Management, LLC has disclosed ABVX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Nantahala Capital Management, LLC's current position in ABVX?

As of Q3 2026, Nantahala Capital Management, LLC holds 198.75K shares of ABVX (ABIVAX SA), valued at $19.68M, representing 0.90% of its reported portfolio and ranking #39.

Has Nantahala Capital Management, LLC been buying or selling ABVX?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in ABVX. The position peaked in Q3 2025 at 557.56K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.